Fifth Lane Capital »

Cardlytics shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Cardlytics (CDLX) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Cardlytics

Tip: Access up to 7 years of quarterly data

All positions including Cardlytics held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardlytics by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 10k 2.43

More positions owned by Fifth Lane Capital

Ishares Tr Core S&p500 Etf (IVV)
Renatus Tactical Acquis Shs Cl A (RTAC)
C1 Common Stock
Cantor Equity Partners Ii In Cl A Ord Shs (CEPT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Procap Acquisition Corp Shs Cl A
Cantor Equity Partners Iii I Shs Cl A (CAEP)
Futurecrest Acquisition Corp Unit 99/99/9999
M3brigade Acquisition V Corp Cl A (MBAV)
Wen Acquisition Corp Com Cl A
Columbus Circle Cap Corp. I Shs Cl A (BRR)
Btc Dev Corp Unit 09/11/2030
UnitedHealth (UNH)
Republic Digital Acquisition Usd Cl A Ord Shs (RDAG)
Live Oak Acquisition Corp V Cl A Shs (LOKV)

View all positions for Fifth Lane Capital

Top funds holding Cardlytics

CAS Investment Partners
Vanguard Group
KPS Global Asset Management UK
683 Capital Management
Worldly Partners Management
Quinn Opportunity Partners
BlackRock
Susquehanna International
Jane Street
Citadel Advisors
Rbf Capital
Geode Capital Management
Frigate Ventures
Citizens Financial Group
LPL Financial

View all funds holding Cardlytics